🇺🇸 FDA
Patent

US 7767677

Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

granted A61KA61K31/496A61K31/501

Quick answer

US patent 7767677 (Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors) held by Xenon Pharmaceuticals Inc. expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/496, A61K31/501, A61P, A61P1/16